Zymeworks (ZYME) Capital Expenditures (2021 - 2026)

Zymeworks has disclosed Capital Expenditures across 6 years of filings, most recently posting $100000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $100000.0, up 525.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $84000.0 (up 425.0% YoY), and the FY2023 annual result was $2.5 million, down 69.64% from the prior year.
• Capital Expenditures came in at $100000.0 for Q1 2026 at Zymeworks, up from -$940000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $6.7 million in Q4 2022 to a low of -$3.2 million in Q2 2022.
• The 5-year median for Capital Expenditures is $419000.0 (2022), against an average of $670250.0.
• Across the five-year window, Capital Expenditures slumped 571.07% in 2024 and jumped 525.0% in 2026, its largest moves.
• Zymeworks' Capital Expenditures stood at $6.7 million in 2022, then slumped by 94.7% to $356000.0 in 2023, then plunged by 571.07% to -$1.7 million in 2024, then jumped by 43.95% to -$940000.0 in 2025, then jumped by 110.64% to $100000.0 in 2026.
• The last three Capital Expenditures figures came in at $100000.0 (Q1 2026), -$940000.0 (Q4 2025), and $410000.0 (Q3 2025), per Business Quant data.